Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
GHK-Cu (Copper Tripeptide) This complex forms when the tripeptide GHK chelates Cu(II)
Clinical trials demonstrate remarkable efficacy in treating withdrawal symptoms, with 97% of opiate-dependent and 87% of alcohol-dependent patients experiencing symptom relief
Levels of free carnitine (CAR), calcium (Ca), inorganic phosphate (P), Ca x P product, parathormone (PTH), bone-specific alkaline phosphatase (b-ALP), osteocalcin (OC), and osteoprotegerin (OPG) were monitored
Please Note: GHK-Cu is supplied in a freeze-dried (lyophilised) form and must be reconstituted with bacteriostatic water before research use to ensure proper mixing and stability
The announcement was widely interpreted as a signal that the FDA under the new administration would take a more permissive stance toward peptide compounding than the 2023 Pharmacy Compounding Advisory Committee position, which had placed BPC-157 firmly in Category 2 (substances the FDA had concerns about for compounding use)
This location corresponds to the watershed zone where blood supply is naturally poorest
